Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Medical Affairs teams are improving alignment and insight generation, but still struggle to drive and measure behavior change. This report highlights key capability gaps, measurement challenges, and practical models for proving impact. Download the report to learn how to move from activity to measurable outcomes. | Medical Affairs teams are improving alignment and insight generation, but still struggle to drive and measure behavior change. This report highlights key capability gaps, measurement challenges, and practical models for proving impact. Download the report to learn how to move from activity to measurable outcomes.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Turn Language Access into an Operational Advantage

How medication intelligence scales trust in healthcare tech innovation

Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026

Epic, Oracle and Cleveland Clinic among companies to joining CMS prior authorization initiative

Two-thirds of health leaders concerned about Medicare, Medicaid cuts’ impact on business operations

Revenue with respect: Applying the golden rule to patient pay

Health system revenue heads increasingly turning their attention to patients' share of the bill

WTW: Employers aiming to bulk up AI use for health and benefits

Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management

OIG: Jury still out on impacts of vertical consolidation in Part D

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…

Healthcare agencies remain at the forefront of pharmaceutical marketing, but new technologies and shifting political dynamics are…

Early-onset cancers are rising among adults 18–49, reshaping how patients are diagnosed, supported, and engaged. This report…

A difference of just a few minutes in communication can translate into shorter hospital stays, fewer readmissions, and…

There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…

Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,